| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
TMO
Thermo Fisher
|
May 27, 2026 | BUY |
Strong Buy
+26.9% avg upside
38 analysts
|
$650.00
39.92% Upside
|
+1.3% |
|
WGS
GeneDx Holdings
|
May 27, 2026 | BUY |
Strong Buy
+35.9% avg upside
9 analysts
|
$100.00
69.52% Upside
|
+27.2% |
|
BIO
Bio-Rad Laboratories
|
May 21, 2026 | HOLD |
Buy
+23.7% avg upside
8 analysts
|
$275.00
2.70% Downside
|
-0.7% |
|
QDEL
QuidelOrtho
|
May 07, 2026 | HOLD |
Buy
+185.5% avg upside
13 analysts
|
$12.50
8.55% Downside
|
+21.9% |
|
QGEN
Qiagen
|
May 07, 2026 | BUY |
Buy
+14.1% avg upside
23 analysts
|
— | -2.2% |
|
DHR
Danaher
|
Apr 22, 2026 | BUY |
Strong Buy
+21.8% avg upside
45 analysts
|
$245.00
38.21% Upside
|
-1.5% |
|
DGX
Quest Diagnostics
|
Apr 21, 2026 | BUY |
Buy
-12.4% avg upside
33 analysts
|
$225.00
15.34% Upside
|
-3.5% |
|
VCYT
Veracyte
|
Apr 12, 2026 | BUY |
Strong Buy
-19.0% avg upside
17 analysts
|
$45.00
16.02% Downside
|
+18.6% |
|
CAI
Caris Life Sciences, Inc.
|
Apr 12, 2026 | BUY |
Strong Buy
+54.5% avg upside
20 analysts
|
$28.00
51.54% Upside
|
-13.8% |
|
TEM
Tempus AI, Inc. Class A
|
Apr 12, 2026 | SELL |
Strong Buy
+33.8% avg upside
19 analysts
|
$35.00
31.14% Downside
|
-10.0% |
|
MTD
Mettler-Toledo
|
Mar 19, 2026 | BUY |
Buy
+2.7% avg upside
18 analysts
|
$1450.00
26.60% Upside
|
-3.0% |
|
MLAB
Mesa Laboratories
|
Mar 11, 2026 | BUY |
Buy
+48.3% avg upside
5 analysts
|
$115.00
21.02% Upside
|
+29.1% |
|
TXG
10x Genomics
|
Feb 13, 2026 | BUY |
Buy
-26.8% avg upside
18 analysts
|
$21.00
39.67% Downside
|
+75.2% |
|
BRKR
Bruker
|
Feb 12, 2026 | BUY |
Buy
-7.0% avg upside
22 analysts
|
$50.00
12.73% Downside
|
+46.1% |
|
AVTR
Avantor
|
Feb 12, 2026 | SELL |
Buy
+49.6% avg upside
26 analysts
|
$8.00
16.45% Downside
|
-5.4% |
|
WAT
Waters
|
Feb 10, 2026 | BUY |
Strong Buy
+3.5% avg upside
30 analysts
|
$470.00
32.33% Upside
|
+9.4% |
|
RVTY
Revvity
|
Feb 02, 2026 | HOLD |
Buy
+5.5% avg upside
23 analysts
|
$105.00
5.07% Upside
|
-8.6% |
|
MRK
Merck & Company
|
Dec 19, 2025 | BUY |
Strong Buy
+10.7% avg upside
43 analysts
|
$139.00
21.97% Upside
|
+15.9% |
|
GH
Guardant Health
|
Dec 17, 2025 | BUY |
Strong Buy
-5.8% avg upside
30 analysts
|
$130.00
1.26% Downside
|
+32.5% |
|
NTRA
Natera
|
Dec 17, 2025 | BUY |
Strong Buy
+7.6% avg upside
26 analysts
|
$275.00
18.91% Upside
|
+0.4% |
|
SERA
Sera Prognostics
|
Dec 14, 2025 | BUY |
Strong Buy
+322.9% avg upside
7 analysts
|
$5.00
185.68% Upside
|
-48.2% |
|
BLLN
BillionToOne, Inc. Class A
|
Dec 01, 2025 | HOLD |
Strong Buy
+16.4% avg upside
8 analysts
|
$117.00
11.32% Upside
|
-10.5% |
|
A
Agilent
|
Oct 17, 2025 | HOLD |
Strong Buy
+3.9% avg upside
32 analysts
|
$130.00
2.29% Upside
|
-6.1% |
|
LH
Labcorp Holdings
|
Jul 25, 2025 | BUY |
Strong Buy
+1.8% avg upside
36 analysts
|
$300.00
17.33% Upside
|
-2.4% |
|
ECL
Ecolab
|
May 20, 2025 | BUY |
Strong Buy
+4.0% avg upside
35 analysts
|
$310.00
15.14% Upside
|
-4.2% |
|
CDXS
Codexis
|
May 14, 2025 | BUY |
Strong Buy
+291.5% avg upside
13 analysts
|
$4.50
75.08% Upside
|
+4.0% |
|
PACB
Pacific Biosciences
|
May 09, 2025 | BUY |
Buy
+214.0% avg upside
14 analysts
|
$3.00
114.28% Upside
|
+25.9% |
|
MYGN
Myriad Genetics
|
Feb 25, 2025 | SELL |
Hold
+315.3% avg upside
24 analysts
|
$11.00
142.19% Upside
|
+59.3% |
|
NEO
NeoGenomics
|
Feb 18, 2025 | BUY |
Strong Buy
+40.2% avg upside
17 analysts
|
$18.00
61.72% Upside
|
-17.3% |
|
BLFS
BioLife Solutions
|
Dec 16, 2024 | BUY |
Strong Buy
+13.0% avg upside
17 analysts
|
$31.00
18.98% Upside
|
-10.1% |
|
ILMN
Illumina
|
Oct 31, 2024 | HOLD |
Buy
-10.0% avg upside
30 analysts
|
$145.00
10.38% Downside
|
-14.3% |
|
CDNA
CareDx
|
Aug 01, 2024 | BUY |
Buy
+26.1% avg upside
16 analysts
|
$30.00
14.65% Upside
|
-48.2% |
|
RGEN
Repligen
|
Jun 03, 2024 | HOLD |
Strong Buy
+28.3% avg upside
25 analysts
|
$165.00
24.90% Upside
|
-17.3% |
|
MRVI
Maravai Lifesciences Holdings
|
Jun 03, 2024 | BUY |
Strong Buy
+175.0% avg upside
17 analysts
|
$11.00
111.45% Upside
|
-74.6% |
|
NAUT
Nautilus Biotechnolgy
|
Jun 03, 2024 | HOLD |
Strong Buy
+404.4% avg upside
5 analysts
|
$3.00
31.67% Upside
|
-71.7% |
|
OSUR
Orasure Technologies
|
May 13, 2024 | HOLD |
Buy
+99.5% avg upside
11 analysts
|
$6.00
41.11% Upside
|
-21.6% |
|
SHC
Sotera Health
|
Jan 23, 2023 | HOLD |
Strong Buy
+30.3% avg upside
13 analysts
|
$18.00
13.76% Upside
|
-13.2% |
|
ICLR
Icon
|
Apr 28, 2022 | BUY |
Strong Buy
+24.0% avg upside
25 analysts
|
$315.00
115.75% Upside
|
-14.4% |
|
RNLXY
Renalytix
|
Apr 01, 2022 | HOLD |
Strong Buy
+800.3% avg upside
5 analysts
|
$8.00
569.94% Upside
|
· |
|
ABSI
AbSci
|
Mar 23, 2022 | BUY |
Strong Buy
+37.3% avg upside
18 analysts
|
$25.00
237.32% Upside
|
-77.2% |
|
SOPH
SOPHiA GENETICS
|
Mar 15, 2022 | BUY |
Strong Buy
+75.8% avg upside
7 analysts
|
$18.00
229.71% Upside
|
-40.8% |
|
RPID
Rapid Micro Biosystems
|
Mar 04, 2022 | BUY |
Strong Buy
+411.7% avg upside
6 analysts
|
$15.00
777.14% Upside
|
-78.5% |
|
QTRX
Quanterix
|
Mar 02, 2022 | BUY |
Buy
+464.7% avg upside
8 analysts
|
$60.00
1669.95% Upside
|
-66.3% |
|
SEER
Seer
|
Mar 01, 2022 | BUY |
Strong Buy
+552.2% avg upside
5 analysts
|
$25.00
1336.75% Upside
|
-71.7% |
|
XRAY
DENTSPLY SIRONA
|
Feb 28, 2022 | HOLD |
Buy
+171.7% avg upside
25 analysts
|
$55.00
432.43% Upside
|
-28.7% |
|
ADPT
Adaptive Biotechnologies
|
Feb 16, 2022 | BUY |
Strong Buy
+20.0% avg upside
14 analysts
|
$50.00
185.31% Upside
|
-37.7% |
|
IQV
IQVIA Holdings
|
Feb 15, 2022 | BUY |
Strong Buy
+34.3% avg upside
38 analysts
|
$310.00
84.81% Upside
|
-0.7% |
|
TWST
Twist Bioscience
|
Feb 04, 2022 | SELL |
Strong Buy
-25.5% avg upside
14 analysts
|
$65.00
25.72% Downside
|
+57.5% |
|
ISRG
Intuitive Surgical
|
Jul 21, 2021 | BUY |
Strong Buy
+29.5% avg upside
36 analysts
|
$333.30
17.98% Downside
|
-28.6% |
|
CRL
Charles River Labs
|
May 28, 2021 | BUY |
Strong Buy
+12.0% avg upside
34 analysts
|
$390.00
110.82% Upside
|
-27.7% |
|
NVST
Envista Holdings
|
Oct 30, 2020 | BUY |
Buy
+13.6% avg upside
19 analysts
|
$30.00
15.82% Upside
|
+48.0% |
|
ARAY
Accuray
|
Dec 13, 2017 | SELL |
Buy
+1693.7% avg upside
9 analysts
|
— | +16.7% |
|
PGEN
Precigen
|
Mar 01, 2017 | HOLD |
Buy
+404.8% avg upside
11 analysts
|
$25.00
418.64% Upside
|
· |
|
TPST
Tempest Therapeutics
|
Aug 04, 2016 | HOLD |
Buy
+1662.1% avg upside
18 analysts
|
$8.00
550.48% Upside
|
-71.9% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.